Stocks · Health care · Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

AQST Clue Score18
United States Fiscal year ends December CIK 0001398733 Results filed 3 Nov 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Sherry Korczynski
9 Sep 2026
Chief Commercial Officer
Sold after exercise
8,750
$5.22
$45.68K
Julie Krop
23 Jun 2026
Director
Sold after exercise
25,000
$5.02
$125.39K
Cassie Jung
15 Oct 2025
Chief Operating Officer
Sold after exercise
67,575
$7.01
$473.70K
Cassie Jung
4 Sep 2025
Chief Operating Officer
Sold after exercise
62,180
$5.00
$310.90K

What was left out

Form 4 filings counted 284
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 4
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 11,746,136
Sales filed before the plan box existed 9
History held since 26 Jul 2018